Ruilong Lan
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Renal and related cancers 2
- Wnt/β-catenin signaling in development and cancer 2
- Bone Metabolism and Diseases 2
- Oncology 11
- Cancer Cells and Metastasis 4
- Co-authors
- Fei Huang (14 shared papers)Kunmei Lai (3 shared papers)Yanfang Xu (3 shared papers)Lurong Zhang (9 shared papers)Junying Chen (12 shared papers)Jianhua Lin (9 shared papers)Jinsheng Hong (10 shared papers)Zeng Wang (3 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (2 papers)Oncology Reports (2 papers)Carcinogenesis (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)Journal of Orthopaedic Surgery and Research (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ruilong Lan
31 papers receiving 547 citations
Peers
Comparison fields: 5 of 93
- Nephrology 52
- Drug Discovery 1
- Pharmacology 36
- Immunology 86
- Cancer Research 55
Countries citing papers authored by Ruilong Lan
This map shows the geographic impact of Ruilong Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruilong Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruilong Lan more than expected).
Fields of papers citing papers by Ruilong Lan
This network shows the impact of papers produced by Ruilong Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruilong Lan. The network helps show where Ruilong Lan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruilong Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 155 | |
| 2 | 2014 | 57 | |
| 3 | 2018 | 40 | |
| 4 | 2023 | 37 | |
| 5 | 2020 | 30 | |
| 6 | 2022 | 27 | |
| 7 | 2017 | 23 | |
| 8 | 2021 | 16 | |
| 9 | 2020 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2018 | 14 | |
| 12 | 2015 | 14 | |
| 13 | Vitronectin significantly influences prognosis in osteosarcoma. | 2015 | 14 |
| 14 | 2017 | 13 | |
| 15 | 2017 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2018 | 10 | |
| 18 | 2022 | 8 | |
| 19 | 2016 | 8 | |
| 20 | 2018 | 7 |
About Ruilong Lan
Ruilong Lan is a scholar working on Molecular Biology, Oncology, Immunology, Nephrology and Electrical and Electronic Engineering, having authored 31 papers that have together received 554 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers), Biomarkers in Disease Mechanisms (2 papers), Renal and related cancers (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Immune cells in cancer (2 papers) and Bone Metabolism and Diseases (2 papers). The work is most often cited by research in Nephrology (52 citations), Drug Discovery (1 citation), Pharmacology (36 citations), Immunology (86 citations) and Cancer Research (55 citations). Ruilong Lan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Fei Huang, Kunmei Lai, Yanfang Xu, Lurong Zhang, Junying Chen, Jianhua Lin, Jinsheng Hong, Zeng Wang, Zhimin Chen and Hui Y. Lan. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Oncology Reports, Carcinogenesis, Frontiers in Bioengineering and Biotechnology and Journal of Orthopaedic Surgery and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.